课题基金 / 基金详情

DEREGULATION OF ONCOGENE EXPRESSION IN HUMAN TUMORS

DEREGULATION OF ONCOGENE EXPRESSION IN HUMAN TUMORS
人类肿瘤中癌基因表达的失调
批准号:
3180918
负责人:
SUSAN M ASTRIN
金额:
$4.18万
依托单位国家:
美国
项目类别:
财政年份:
1985
资助国家:
美国
项目状态:
已结题
起止时间:
1985-07-01 至 1989-04-04

项目摘要

项目成果

SUSAN M ASTRIN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Our long-range goal is to elucidate mechanisms of oncogene activation in human tumors and to assess the possiblity that genetic lesions in trans-acting regulators of oncogene expression play an important role in this activation. Towards this goal, we have cloned the human c-myc gene to generate probes to be used for quantitation of myc sequences in RNAs prepared from a variety of human tumors. Using these probes, we have observed elevated expression (greater than 10-fold above levels in normal tissue) of the c-myc gene in tumor cells obtained from certain leukemia/lymphoma and colon carcinoma patients. Studies with colon carcinoma cell lines have shown that, in samples with elevated expression, myc is deregulated; i.e., the normal cell cycle control is lost and the gene is constitutively expressed. In addition, we have observed that, in the vast majority of cases, elevated expression of the myc gene in the tumor cells is not due to detectable rearrangements or amplification of the myc locus itself. Further structural analysis of the myc locus in these tumors will be performed using cloning and sequencing technology. Two types of models for the activation, due to either cis-acting or trans-acting elements, will be tested. In order to test for alterations at the myc locus itself (cis-acting effects) which result in enhanced expression, myc loci cloned from tumors will be tested for transcriptional activity after transfection into recipient cells with low levels of endogenous myc expression. To test for lesions at other loci which may affect myc expression (trans-acting effects), cell fusions wil be performed between tumor cells expressing myc at high levels and normal cells having low levels of myc expression. Defective negative acting regulatory genes in the tumor cells would be complemented in this assay by alleles in the normal cells resulting in a low level of myc expression in the hybrid cells. Experiments designed to test for positive acting regulatory elements are also proposed. Ultimately, we would hope to clone and study the products of any regulatory loci identified in this manner. (X)
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ONCOGENIC POTENTIAL OF HIV
ONCOGENIC POTENTIAL OF HIV
ONCOGENIC POTENTIAL OF HIV
ONCOGENIC POTENTIAL OF HIV
海外基金